Celon Pharma SA
WSE:CLN
Wall Street
Price Targets
CLN Price Targets Summary
Celon Pharma SA
According to Wall Street analysts, the average 1-year price target for CLN is 27.74 PLN with a low forecast of 15.66 PLN and a high forecast of 40.95 PLN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CLN's stock price target?
Price Target
27.74
PLN
According to Wall Street analysts, the average 1-year price target for CLN is 27.74 PLN with a low forecast of 15.66 PLN and a high forecast of 40.95 PLN.
What is Celon Pharma SA's Revenue forecast?
Projected CAGR
9%
For the last 7 years the compound annual growth rate for Celon Pharma SA's revenue is 8%. The projected CAGR for the next 4 years is 9%.